跳至主要内容
临床试验/RBR-105wyncc
RBR-105wyncc尚未招募4 期

se of platelet rich plasma and hyaluronic acid in rotator cuff injuries

Prevent Senior0 个研究点开始时间: 2021年11月12日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
40Y 至 85Y(—)

入选标准

  • Adults aged between 40 and 85 years, regardless of gender; clinical and radiological diagnosis of tendinopathy or partial bursal lesions <50% of the supra and infraspinatus thickness; availability of follow-up during the study period; provided voluntary written consent to participate in the study, confirmed by signing the informed consent form

排除标准

  • Having other joint diseases or joint trauma, autoimmune diseases or intra-articular medication in the last 12 months; history of acute or chronic communicable diseases, including hepatitis B, hepatitis C and HIV; history of systemic bone or cartilaginous disorders; evidence of active infection or history of infection in the joint to be infiltrated in this study; comorbidity that the physician considers as a contraindication for the infiltration of platelet-rich plasma; chronic treatment with anticoagulant or immunosuppressive drugs; previous surgery (at any time) of the affected shoulder; presence of at least one of the following diseases: adhesive capsulitis, calcareous tendonitis, glenohumeral arthrosis or acromioclavicular joint disease

研究者

发起方
Prevent Senior

相似试验